High biological age linked to increased risk of stroke and dementia

People who have a higher biological age than their actual chronological age have a significantly increased risk of stroke and dementia, especially vascular dementia.

Lilly agrees to buy POINT Biopharma for $1.4bn

Lilly offered an acquisition price of $12.5 for each share of POINT. Credit: Michael Vi/Shutterstock.com. Eli Lilly and Company has signed a definitive agreement for

October 4, 2023

Emerging Depression Tied to Earliest Alzheimer’s Pathology

Depressive symptoms were tied to early changes in Alzheimer’s pathology in regions associated with emotional control. Greater depressive symptoms were associated with amyloid accumulation in

August 30, 2024

Childhood vaccination rates, a rare health bright spot in struggling states, are slipping

Jen Fisher can do only so much to keep her son safe from the types of infections that children can encounter at school. The rest,

January 16, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.